On March 4, the House passed H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123), which was passed by the Senate on March 5 and signed into law by the President on March 6. This emergency appropriations package included a funding directed to HHS, the State Department, the Small Business Administration (SBA), and the United States Agency for International Development (USAID).
Below is a summary of the bill's key provisions:
- Provides $8.3 billion in emergency funding in response to the coronavirus outbreak for:
- The development and manufacturing of vaccines and other supplies
- State, local and tribal public health agencies
- Loans for affected small businesses
- Evacuations and emergency preparedness activities
- Humanitarian assistance for affected countries
- Supplemental appropriations will be provided to the FDA, CDC, NIH, Public Health and Social Services Emergency Fund, Small Business Administration, Department of State, and USAID.
- Designates the supplemental appropriations as emergency spending, which is exempt from discretionary spending limits.